Drug profile · INN
ferric derisomaltose
MONOFER
ferric derisomaltose (MONOFER) is a supplement. Associated with A.Menarini Australia Pty Limited. Route of administration: intravenous. Current US regulatory status: approved.
Drug details — ferric derisomaltose
- US status
- approved
- Class
- —
- Route
- INTRAVENOUS
- Patents
- 0
- Programs
- 5
- Data quality
- 0.84
Quick answer
ferric derisomaltose (MONOFER) is a supplement. Associated with A.Menarini Australia Pty Limited. Route of administration: intravenous. Current US regulatory status: approved.
Key facts
Mechanism of action
Supplement
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| TGA | approved | — |
Pipeline programs
Frequently asked questions
What is ferric derisomaltose?
ferric derisomaltose (MONOFER) is a supplement. Associated with A.Menarini Australia Pty Limited. Route of administration: intravenous. Current US regulatory status: approved.
What is the brand name for ferric derisomaltose?
MONOFER is a marketed brand name for ferric derisomaltose. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ferric derisomaltose?
ferric derisomaltose has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.